Progyny price to free cash flow PGNY

Market value divided by free cash flow over the last twelve months, since 2020.

Today, Oct 23, 2026: 12.5×
6-year median: 19.8×
Against its 6-year history: 34th; percentile: 0 is its lowest day, 100 its highest
6-year range: 7.0× to 409×
Peer median: 18.4×

Progyny's price to free cash flow is 12.5× as of Oct 23, 2026.

That is below its 6-year median of 19.8×, lower than on 66% of days in the last 6 years.

Over that time it ranged from 7.0× in Apr 2026 to 409× in Sep 2021.

The median for 10 hospital and care facility stocks of a similar size is 18.4×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	12.5×	7.0×	13.6×
2025	11.5×	8.5×	12.3×
2024	9.0×	7.3×	19.9×
2023	17.9×	14.5×	95.6×
2022	83.7×	82.8×	290×
2021	206×	108×	409×
2020	175×	126×	227×

Against its peers

Companies in Medical - Care Facilities nearest Progyny's size, closest first, today.

Company	Price to free cash flow
PGNYProgyny	12.5×
ADUSAddus HomeCare	14.7×
MDPediatrix Medical	10.4×
HCSGHealthcare Services	11.7×
ARDTArdent Health	5.7×
PRVAPrivia Health	n/m
AVAHAveanna Healthcare	18.4×
PNTGPennant	42.2×
NHCNational Healthcare	25.2×
USPHU S Physical Therapy	20.6×
OMDAOmada Health	51.0×
Peer median	18.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Progyny

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.